From: Persistence and compliance to antidepressant treatment in patients with depression: A chart review
Odds Ratio (95% CI; p value) | |||
---|---|---|---|
Persistence to Initial Antidepressant | |||
Month 1 a | Month 3 b | Month 6 c | |
Sulpiride (n = 148) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
Paroxetine (n = 114) | 0.60 (0.34–1.06; p = 0.08) | 0.61 (0.36–1.04; p = 0.07) | 0.76 (0.43–1.34; p = 0.35) |
Fluvoxamine (n = 34) | 0.80 (0.35–1.82; p = 0.59) | 0.49 (0.21–1.12; p = 0.09) | 0.59 (0.23–1.49; p = 0.27) |
Sertraline (n = 33) | 1.68 (0.67–4.18; p = 0.27) | 1.32 (0.60–2.91; p = 0.49) | 2.59 (1.16–5.77; p = 0.02) |
Milnacipran (n = 31) | 1.13 (0.47–2.71; p = 0.78) | 1.40 (0.63–3.13; p = 0.41) | 0.56 (0.21–1.49; p = 0.25) |
Amoxapine (n = 5) | 0.00 (0.0-0.0; p = 0.99) | 0.00 (0.0-0.0; p = 0.99) | 0.00 (0.0-0.0; p = 0.99) |
Trazodone (n = 2) | 1.13 (0.12–11.1; p = 0.92) | 1.13 (0.18–7.35; p = 0.90) | 0.33 (0.03–3.28; p = 0.35) |
Persistence to Any Antidepressant | |||
Month 1d | Month 3 e | Month 6 f | |
Sex | |||
Female (n = 197) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
Male (n = 170) | 2.37 (1.44–3.90; p = 0.001) | 1.42 (0.93–2.17; p = 0.10) | 1.29 (0.84–1.97; p = 0.24) |
Age groups | |||
Before age 40 (n = 241) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
40–59 (n = 95) | 1.01 (0.57–1.79; p = 0.97) | 1.43 (0.87–2.33; p = 0.16) | 1.02 (0.62–1.66; p = 0.95) |
60 or older (n = 31) | 0.70 (0.31–1.59; p = 0.40) | 1.38 (0.65–2.96; p = 0.41) | 1.96 (0.91–4.21; p = 0.08) |
Anxiolytics use | |||
No (n = 245) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
Yes (n = 122) | 2.14 (1.22–3.73, p = 0.008) | 1.30 (0.82–2.04, p = 0.27) | 1.38 (0.87–2.17, p = 0.17) |
Hypnotics use | |||
No (n = 191) | 1.00 (reference) | 1.00 (reference) | 1.00 (reference) |
Yes (n = 176) | 1.44 (0.88–2.36, p = 0.15) | 1.24 (0.81–1.90, p = 0.33) | 1.35 (0.87–2.17, p = 0.17) |